Study of the Corheart 6 left ventricular assist system
Part of Heart & circulation clinical trials.
This trial tests a heart pump (Corheart 6) for people with severe heart failure who are not getting better with other treatments. It may help if you need a heart assist device.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your heart pumps less than 25% of blood out with each beat (ejection fraction).
- You have severe heart failure (NYHA class IV), meaning you are short of breath even at rest.
- You cannot exercise due to heart failure, or your oxygen intake is very low.
- You have worsening kidney or liver function from poor blood flow, or you need a temporary heart pump or IV medications.
- You do not have any other options like a special pacemaker or defibrillator.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how well a small heart pump (Corheart 6 LVAS) works over time for people with severe heart failure that hasn't improved with standard treatments. It aims to help those who need extra support to keep their heart pumping.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This study follows people who have already received the Corheart 6 heart pump to see how well it works over time. You may qualify if you have severe heart failure that doesn't improve with standard treatments and you got the pump after October 1, 2021.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
This trial tests a new left ventricular assist device (LVAD) for people with advanced heart failure who are not responding to standard treatments and are eligible for a heart transplant. The pump helps the heart circulate blood.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
Hear when a new Advanced Left Ventricular Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.